Health CanadaGeneral Alert
Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc.
Published: September 1, 2001Recall ID: 24560Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc.
Recalling Firm: Marketed health products
Product Description & Identification
Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc.
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24560 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-conditional-approval-gleevec-imatinib-novartis-pharma-canada-inc |
| Title | Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc. |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2001-09-01 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc. Check if your household is affected: https://therecallfile.com/recalls/archived-conditional-approval-of-gleevec-imatinib-novartis-pharma-cana/CANADA-24560
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordArchived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc.